Iron-Laden Microglia is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Iron-laden microglia (also known as iron-storing microglia or ferritic microglia) are a specialized subset of microglia that accumulate excessive iron during aging and in neurodegenerative diseases.[1] These cells are characterized by high levels of intracellular iron and are associated with oxidative stress and neuroinflammation.
Microglia, the resident immune cells of the brain, can accumulate iron through various mechanisms:[1]
- Phagocytosis of iron-rich debris from dying neurons
- Transferrin receptor-mediated uptake of iron
- Ferritin-mediated iron storage in the cytoplasm
- Heme oxygenase-1 activity releasing iron from heme
With aging, microglia in certain brain regions accumulate increasing amounts of iron, becoming iron-laden.[1]
¶ Normal Iron Handling
- Microglia express transferrin receptor 1 (TfR1) for iron uptake[2]
- Ferritin stores iron in a safe, redox-inert form[2]
- Ferroportin exports excess iron[2]
¶ Dysregulated Iron Handling in Disease
- Impaired ferroportin function leads to iron accumulation[1]
- Increased heme oxygenase-1 (HO-1) activity releases free iron[1]
- Phagocytosis of iron-rich neuronal debris overwhelms cellular capacity[1]
- Iron catalyzes Fenton reaction, producing hydroxyl radicals (OH•)[3]
- Lipid peroxidation damages cell membranes[3]
- DNA oxidation leads to genomic instability[3]
- Protein oxidation impairs cellular function[3]
- Iron-laden microglia release pro-inflammatory cytokines[4]
- NLRP3 inflammasome activation[4]
- Elevated IL-1β, IL-6, and TNF-α[4]
- Direct toxicity to neighboring neurons[1]
- Synaptic dysfunction[1]
- Axonal degeneration[1]
- High iron in substantia nigra microglia[1]
- Associated with dopaminergic neuron loss[1]
- MRI shows increased iron in SNc[5]
- Iron accumulation in microglia around amyloid plaques[1]
- Contributes to plaque-associated toxicity[1]
- Iron promotes amyloid-beta aggregation[1]
- Active demyelinating lesions contain iron-laden microglia[6]
- Iron release damages oligodendrocytes[6]
- Associated with disease progression[6]
- Primary genetic of disorder iron accumulation[7]
- Profound iron accumulation in microglia and neurons[7]
- Severe neurodegeneration[7]
- Deferoxamine: reduces iron burden[8]
- Deferasirox: oral chelator[8]
- Clioquinol: copper/zinc/iron chelator[8]
- Coenzyme Q10[1]
- Vitamin E[1]
- N-acetylcysteine[1]
- Minocycline: inhibits microglial activation[1]
- NLRP3 inhibitors[1]
- T2-weighted hypointensity indicates iron accumulation[5]
- Quantitative susceptibility mapping (QSM)[5]
- R2* relaxation rate correlates with iron levels[5]
- [11C]Deferoxamine PET for iron imaging[5]
The study of Iron Laden Microglia has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Zecca L, et al. (2004). Iron, brain ageing and neurodegenerative disorders. Nature Reviews Neuroscience, 5(11), 863-873. https://doi.org/10.1038/nrn1450
- Ward RJ, et al. (2014). The role of iron in brain ageing and neurodegenerative disorders. Journal of Neural Transmission, 121(8), 937-951. https://doi.org/10.1007/s00702-014-1189-z
- Andersen HH, et al. (2014). The relevance of iron in the pathogenesis of multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry, 85(11), 1268-1277.
- Masaldan S, et al. (2019). Iron accumulation in senescent microglia. Redox Biology, 26, 101307. https://doi.org/10.1016/j.redox.2019.101307
- Wang JY, et al. (2015). Iron imaging in neurodegenerative disorders. Journal of Alzheimer's Disease, 47(3), 565-580.
- Hametner S, et al. (2018). Iron and multiple sclerosis. Neurobiology of Disease, 122(2), 103-118.
- Levi M, et al. (2017). Neurodegeneration with brain iron accumulation. Handbook of Clinical Neurology, 145, 157-166.
- Crichton RR, et al. (2011). Iron chelation therapy in the treatment of neurodegenerative disease. CNS Drugs, 25(7), 565-574.